Carlos Mendez‐Dorantes
ORCID: 0000-0002-8190-8568Also affiliated with Harvard University, Dana-Farber Cancer Institute, Massachusetts Institute of Technology
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 8 papers. Top paper: “The RAD52 S346X variant reduces risk of developing breast cancer in carriers of pathogenic germline BRCA2 mutations”.
Yuan Chun Ding, Carlos Mendez‐Dorantes, Adam M. Bailis, Jeremy M. Stark, Susan L. Neuhausen +1 more
Trevor van Eeuwen, David Hoyos, Arthur O. Zalevsky, Egor P. Tchesnokov, Roberto Sánchez +40 more
Xuya Wang, Carlos Mendez‐Dorantes, Paolo Mita, Song Cao, Mark Grivainis +6 more
Michael A. Gillette, Pamela Santiago, Eric Kuhn, Michael Burgess, Kristen Doucette +15 more
Kathleen H. Burns, Carlos Mendez‐Dorantes
Lena Wedeken, José Ortiz, Heather N. Zook, Jeanne M. LeBon, Angela Luo +13 more
Ching Ouyang, Yue Qi, Carlos Mendez‐Dorantes, Alaysia Coblentz, Jackelyn A. Alva-Ornelas +4 more
Linda Jillianne Tsai, Eva Jahanshir, Felicia Wednesday Lopezcolorado, Jeremy M. Stark, Carlos Mendez‐Dorantes